Logo image of ARMO

ARMO BIOSCIENCES INC (ARMO) Stock Price, Quote, News and Overview

NASDAQ:ARMO - Nasdaq - US04225U1043

49.98  +0.01 (+0.02%)

After market: 49.94 -0.04 (-0.08%)

ARMO Quote, Performance and Key Statistics

ARMO BIOSCIENCES INC

NASDAQ:ARMO (6/21/2018, 8:13:59 PM)

After market: 49.94 -0.04 (-0.08%)

49.98

+0.01 (+0.02%)

Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
Statistics
52 Week High57.19
52 Week Low25.1
Market Cap1.52B
Shares30.41M
FloatN/A
Yearly Dividend0
Dividend Yield0%
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPON/A N/A


ARMO short term performance overview.The bars show the price performance of ARMO in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10 15 20 25

ARMO long term performance overview.The bars show the price performance of ARMO in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of ARMO is 49.98 null. In the past month the price increased by 0.16%.

ARMO BIOSCIENCES INC / ARMO Daily stock chart

About ARMO

Company Profile

ARMO Biosciences, Inc. is a clinical-stage biopharmaceutical company. It focuses on developing immunotherapies for the treatment of cancer, cardiovascular disease, fibrosis and inflammation. The Company's platform molecule AM0010 is a pegylated form of recombinant human IL-10, which has immune stimulating effects which induce the activation, proliferation and survival of intratumoral, tumor-reactive, cytotoxic CD8 T cells in cancer patients. Its product pipeline includes AM0001, an anti-PD-1 checkpoint inhibitor; AM0003 an anti-LAG-3 checkpoint inhibitor; AM0015 a form of recombinant human Interleukin-15 cytokine and AM0012 a form of recombinant human Interleukin-12 cytokine. ARMO Biosciences, Inc. is based in REDWOOD CITY, United States.

Company Info

ARMO BIOSCIENCES INC

575 Chesapeake Drive

Redwood City CA 94063

CEO: Peter Van Vlasselaer

Phone: 650-779-5075

ARMO BIOSCIENCES INC / ARMO FAQ

What is the stock price of ARMO BIOSCIENCES INC today?

The current stock price of ARMO is 49.98 null. The price increased by 0.02% in the last trading session.


What is the ticker symbol for ARMO BIOSCIENCES INC stock?

The exchange symbol of ARMO BIOSCIENCES INC is ARMO and it is listed on the Nasdaq exchange.


On which exchange is ARMO stock listed?

ARMO stock is listed on the Nasdaq exchange.


What is ARMO BIOSCIENCES INC worth?

ARMO BIOSCIENCES INC (ARMO) has a market capitalization of 1.52B null. This makes ARMO a Small Cap stock.


What are the support and resistance levels for ARMO BIOSCIENCES INC (ARMO) stock?

ARMO BIOSCIENCES INC (ARMO) has a support level at 49.97 and a resistance level at 49.98. Check the full technical report for a detailed analysis of ARMO support and resistance levels.


Should I buy ARMO BIOSCIENCES INC (ARMO) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ARMO BIOSCIENCES INC (ARMO) stock pay dividends?

ARMO does not pay a dividend.


What is the Price/Earnings (PE) ratio of ARMO BIOSCIENCES INC (ARMO)?

ARMO BIOSCIENCES INC (ARMO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-28.52).


ARMO Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to ARMO.


Chartmill TA Rating
Chartmill Setup Rating

ARMO Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to ARMO. The financial health of ARMO is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ARMO Financial Highlights

Over the last trailing twelve months ARMO reported a non-GAAP Earnings per Share(EPS) of -28.52. The EPS decreased by -8.7% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -24.23%
ROE -27.05%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)-8.7%
Revenue 1Y (TTM)N/A

ARMO Ownership and Analysts


Ownership
Inst Owners40.94%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
AnalystsN/A
Price TargetN/A
EPS Next Y91.8%
Revenue Next YearN/A